List of MeSH codes (C19)
The following is a partial list of the "C" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM).
This list continues the information at List of MeSH codes (C18). Codes following these are found at List of MeSH codes (C20). For other MeSH codes, see List of MeSH codes.
The source for this content is the set of 2006 MeSH Trees from the NLM.
MeSH C19 – endocrine system diseases
MeSH C19.053.098 – adrenal cortex diseases
- MeSH C19.053.098.265 – adrenal cortex neoplasms
- MeSH C19.053.098.265.500 – adrenocortical adenoma
- MeSH C19.053.098.265.750 – adrenocortical carcinoma
MeSH C19.053.347 – adrenal gland neoplasms
- MeSH C19.053.347.500 – adrenal cortex neoplasms
- MeSH C19.053.347.500.500 – adrenocortical adenoma
- MeSH C19.053.347.500.750 – adrenocortical carcinoma
MeSH C19.053.440 – adrenal hyperplasia, congenital
MeSH C19.053.500 – adrenal insufficiency
- MeSH C19.053.500.263 – addison disease
- MeSH C19.053.500.270 – adrenoleukodystrophy
- MeSH C19.053.500.480 – hypoaldosteronism
- MeSH C19.053.500.740 – waterhouse-friderichsen syndrome
MeSH C19.053.800 – adrenocortical hyperfunction
- MeSH C19.053.800.367 – cushing syndrome
- MeSH C19.053.800.604 – hyperaldosteronism
- MeSH C19.053.800.604.249 – bartter syndrome
MeSH C19.246.099 – diabetes complications
- MeSH C19.246.099.500 – diabetic angiopathies
- MeSH C19.246.099.500.191 – diabetic foot
- MeSH C19.246.099.500.382 – diabetic retinopathy
- MeSH C19.246.099.750 – diabetic coma
- MeSH C19.246.099.750.490 – hyperglycemic hyperosmolar nonketotic coma
- MeSH C19.246.099.812 – diabetic ketoacidosis
- MeSH C19.246.099.875 – diabetic nephropathies
- MeSH C19.246.099.937 – diabetic neuropathies
- MeSH C19.246.099.937.250 – diabetic foot
- MeSH C19.246.099.968 – fetal macrosomia
MeSH C19.246.200 – diabetes, gestational
MeSH C19.246.240 – diabetes mellitus, experimental
MeSH C19.246.267 – diabetes mellitus, type 1
MeSH C19.246.300 – diabetes mellitus, type 2
- MeSH C19.246.300.500 – diabetes mellitus, lipoatrophic
MeSH C19.246.774 – prediabetic state
MeSH C19.297.312 – dwarfism, pituitary
MeSH C19.344.078 – adrenal gland neoplasms
- MeSH C19.344.078.265 – adrenal cortex neoplasms
- MeSH C19.344.078.265.500 – adrenocortical adenoma
- MeSH C19.344.078.265.750 – adrenocortical carcinoma
MeSH C19.344.400 – multiple endocrine neoplasia
- MeSH C19.344.400.500 – multiple endocrine neoplasia type 1
- MeSH C19.344.400.505 – multiple endocrine neoplasia type 2a
- MeSH C19.344.400.510 – multiple endocrine neoplasia type 2b
MeSH C19.344.410 – ovarian neoplasms
- MeSH C19.344.410.398 – granulosa cell tumor
- MeSH C19.344.410.464 – luteoma
- MeSH C19.344.410.531 – meigs syndrome
- MeSH C19.344.410.648 – sertoli-leydig cell tumor
- MeSH C19.344.410.765 – thecoma
MeSH C19.344.421 – pancreatic neoplasms
- MeSH C19.344.421.249 – adenoma, islet cell
- MeSH C19.344.421.249.500 – insulinoma
- MeSH C19.344.421.500 – carcinoma, islet cell
- MeSH C19.344.421.500.124 – gastrinoma
- MeSH C19.344.421.500.249 – glucagonoma
- MeSH C19.344.421.500.500 – somatostatinoma
- MeSH C19.344.421.500.750 – vipoma
- MeSH C19.344.421.750 – carcinoma, pancreatic ductal
MeSH C19.344.473 – paraneoplastic endocrine syndromes
MeSH C19.344.525 – parathyroid neoplasms
MeSH C19.344.609 – pituitary neoplasms
- MeSH C19.344.609.145 – acth-secreting pituitary adenoma
- MeSH C19.344.609.145.500 – nelson syndrome
- MeSH C19.344.609.292 – growth hormone-secreting pituitary adenoma
- MeSH C19.344.609.792 – prolactinoma
MeSH C19.344.762 – testicular neoplasms
- MeSH C19.344.762.500 – sertoli-leydig cell tumor
MeSH C19.344.894 – thyroid neoplasms
MeSH C19.391.482 – hypogonadism
- MeSH C19.391.482.293 – eunuchism
- MeSH C19.391.482.600 – kallmann syndrome
- MeSH C19.391.482.629 – klinefelter syndrome
- MeSH C19.391.482.814 – sexual infantilism
MeSH C19.391.630 – ovarian diseases
- MeSH C19.391.630.050 – anovulation
- MeSH C19.391.630.450 – oophoritis
- MeSH C19.391.630.580 – ovarian cysts
- MeSH C19.391.630.580.765 – polycystic ovary syndrome
- MeSH C19.391.630.611 – ovarian failure, premature
- MeSH C19.391.630.642 – ovarian hyperstimulation syndrome
- MeSH C19.391.630.705 – ovarian neoplasms
- MeSH C19.391.630.705.265 – brenner tumor
- MeSH C19.391.630.705.331 – carcinoma, endometrioid
- MeSH C19.391.630.705.398 – granulosa cell tumor
- MeSH C19.391.630.705.464 – luteoma
- MeSH C19.391.630.705.531 – meigs syndrome
- MeSH C19.391.630.705.648 – sertoli-leydig cell tumor
- MeSH C19.391.630.705.765 – thecoma
MeSH C19.391.690 – puberty, delayed
MeSH C19.391.693 – puberty, precocious
MeSH C19.391.775 – sex differentiation disorders
- MeSH C19.391.775.129 – adrenogenital syndrome
- MeSH C19.391.775.260 – freemartinism
- MeSH C19.391.775.309 – gonadal dysgenesis
- MeSH C19.391.775.309.193 – gonadal dysgenesis, 46,xx
- MeSH C19.391.775.309.388 – gonadal dysgenesis, 46,xy
- MeSH C19.391.775.309.391 – gonadal dysgenesis, mixed
- MeSH C19.391.775.309.872 – turner syndrome
- MeSH C19.391.775.316 – hermaphroditism
- MeSH C19.391.775.316.313 – hermaphroditism, true
- MeSH C19.391.775.316.627 – pseudohermaphroditism
- MeSH C19.391.775.316.627.500 – androgen-insensitivity syndrome
- MeSH C19.391.775.370 – hyperandrogenism
- MeSH C19.391.775.425 – kallmann syndrome
- MeSH C19.391.775.454 – klinefelter syndrome
MeSH C19.391.829 – testicular diseases
- MeSH C19.391.829.258 – cryptorchidism
- MeSH C19.391.829.493 – orchitis
- MeSH C19.391.829.782 – testicular neoplasms
- MeSH C19.391.829.782.500 – sertoli-leydig cell tumor
MeSH C19.642.355 – hyperparathyroidism
- MeSH C19.642.355.239 – hyperparathyroidism, primary
- MeSH C19.642.355.480 – hyperparathyroidism, secondary
- MeSH C19.642.355.480.500 – renal osteodystrophy
MeSH C19.642.482 – hypoparathyroidism
- MeSH C19.642.482.500 – digeorge syndrome
MeSH C19.642.713 – parathyroid neoplasms
MeSH C19.700.159 – diabetes insipidus
- MeSH C19.700.159.750 – diabetes insipidus, neurogenic
- MeSH C19.700.159.875 – wolfram syndrome
MeSH C19.700.355 – hyperpituitarism
- MeSH C19.700.355.179 – acromegaly
- MeSH C19.700.355.528 – gigantism
- MeSH C19.700.355.600 – hyperprolactinemia
- MeSH C19.700.355.800 – pituitary acth hypersecretion
MeSH C19.700.482 – hypopituitarism
- MeSH C19.700.482.311 – dwarfism, pituitary
MeSH C19.700.490 – inappropriate adh syndrome
MeSH C19.700.734 – pituitary neoplasms
- MeSH C19.700.734.145 – acth-secreting pituitary adenoma
- MeSH C19.700.734.145.500 – nelson syndrome
- MeSH C19.700.734.292 – growth hormone-secreting pituitary adenoma
- MeSH C19.700.734.792 – prolactinoma
MeSH C19.874.255 – euthyroid sick syndromes
MeSH C19.874.283 – goiter
- MeSH C19.874.283.300 – goiter, endemic
- MeSH C19.874.283.501 – goiter, nodular
- MeSH C19.874.283.601 – goiter, substernal
- MeSH C19.874.283.605 – graves disease
- MeSH C19.874.283.605.500 – graves ophthalmopathy
- MeSH C19.874.283.802 – lingual goiter
MeSH C19.874.397 – hyperthyroidism
- MeSH C19.874.397.370 – graves disease
- MeSH C19.874.397.370.500 – graves ophthalmopathy
- MeSH C19.874.397.685 – thyrotoxicosis
- MeSH C19.874.397.685.905 – thyroid crisis
MeSH C19.874.410 – hyperthyroxinemia
- MeSH C19.874.410.249 – hyperthyroxinemia, familial dysalbuminemic
- MeSH C19.874.410.500 – thyroid hormone resistance syndrome
MeSH C19.874.689 – thyroid dysgenesis
- MeSH C19.874.689.500 – lingual thyroid
- MeSH C19.874.689.500.500 – lingual goiter
MeSH C19.874.788 – thyroid neoplasms
MeSH C19.874.871 – thyroiditis
- MeSH C19.874.871.102 – thyroiditis, autoimmune
- MeSH C19.874.871.102.500 – hashimoto disease
- MeSH C19.874.871.102.750 – postpartum thyroiditis
- MeSH C19.874.871.900 – thyroiditis, subacute
- MeSH C19.874.871.910 – thyroiditis, suppurative
MeSH C19.874.902 – thyrotoxicosis
- MeSH C19.874.902.905 – thyroid crisis
gollark: The problematic bit is dealing with teleporters but I have ways to
gollark: Inasmuch as you can connect up stupidly big batteries to it and/or just a fusion reactor.
gollark: I don't think there's a real limit.
gollark: Well, there is, in the form of the GTech Integrated Shield Defense System™.
gollark: <@465216754684002305> I don't know if I explained it to you, but there are ways through RFT force fields.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.